Verified· 2 sources

Curaxon AG

Summary

About the company

The core activity of Curaxon Ltd. is the development and marketing of innovative drugs for the treatment of neurodegenerative diseases of the central nervous system (CNS), particularly those with high medical need and insufficient therapeutic options. To this end, the company modifies existing active ingredients to improve their pharmacokinetic and pharmacodynamic properties and to exploit new mechanisms of action in order to achieve higher therapeutic efficacy.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered2

Development of new medicines

Development of new medicines for neurodegenerative diseases with high medical need, in particular through chemical modification of existing active ingredients and new mechanisms of action.

Development of innovative therapies for central nervous system disorders

Innovative therapies for patients with central nervous system disorders, focusing on high therapeutic efficacy and improved pharmacokinetic and pharmacodynamic properties.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Curaxon AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Curaxon AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Curaxon AG in comparison

Industry comparisons are coming soon

Similar companies